Androgen Receptor, Implications for Health and Wellbeing: Natural History Study of Individuals With Androgen Insensitivity
NCT04708431
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
Background: Androgen effects in humans are usually (but not always) mediated by the androgen receptor which is coded for by the androgen receptor gene (AR gene). Androgen Insensitivity Syndrome (AIS) is a rare condition in which the body cannot sense the male hormones in the blood or tissue. Both women and men can be affected by AIS. Researchers want to learn more about the health of people with AIS over time.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Androgen Insensitivity Syndrome
- Metabolic Parameters in AIS, CAIS, PAIS and MAIS
- Tumor Formation in AIS, CAIS, PAIS and MAIS
- Sexual Function AIS, CAIS, PAIS and MAIS
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 8 to 99 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Last updated on ClinicalTrials.gov
- August 13, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Maryland · 1
- National Institutes of Health Clinical Center · Bethesda, MD
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.